| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
2,630,000,000 |
| Market
Cap: |
405.76(B) |
| Last
Volume: |
7,590,777 |
Avg
Vol: |
8,301,717 |
| 52
Week Range: |
$144.45 - $174.48 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
| |
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
| |
MAJOR MARKET |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 21 |
| Guru Rank Value : 20.3 |
| Guru Occurances : 6 |
|
|
|
|
|
| |
|
Company Profile Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
8,891 |
68,288 |
115,451 |
522,170 |
| Total Sell Value |
$1,441,765 |
$10,723,734 |
$18,652,688 |
$88,845,171 |
| Total People Sold |
1 |
2 |
5 |
10 |
| Total Sell Transactions |
1 |
2 |
5 |
24 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ullmann Michael H |
Exec VP, General Counsel |
• • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,309 |
128,294 |
|
- |
|
| Gorsky Alex |
Chairman, CEO |
• • – |
2019-02-08 |
4 |
D |
$132.00 |
$1,545,456 |
D/D |
(11,708) |
340,756 |
|
- |
|
| Gorsky Alex |
Chairman, CEO |
• • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,579 |
352,464 |
|
- |
|
| Wolk Joseph J |
Exec VP, CFO |
• • – |
2019-02-08 |
4 |
D |
$132.00 |
$97,284 |
D/D |
(737) |
11,502 |
|
- |
|
| Wolk Joseph J |
Exec VP, CFO |
• • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,540 |
12,239 |
|
- |
|
| Mcevoy Ashley |
EVP, WW Chair, Medical Devices |
• • – |
2019-02-08 |
4 |
D |
$132.00 |
$240,768 |
D/D |
(1,824) |
14,268 |
|
- |
|
| Mcevoy Ashley |
EVP, WW Chair, Medical Devices |
• • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,599 |
16,092 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2019-02-08 |
4 |
D |
$132.00 |
$96,756 |
D/D |
(733) |
15,392 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,484 |
16,125 |
|
- |
|
| Mulcahy Anne M |
Director |
• • – |
2018-12-14 |
4 |
B |
$133.76 |
$100,050 |
D/D |
748 |
6,537 |
2.39 |
- |
|
| Prince Charles |
Director |
• • – |
2018-12-14 |
4 |
B |
$134.37 |
$268,731 |
D/D |
2,000 |
28,520 |
2.39 |
- |
|
| Perez William D |
Director |
• • – |
2018-12-14 |
4 |
B |
$133.91 |
$133,910 |
D/D |
1,000 |
9,122 |
2.39 |
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2018-12-13 |
4 |
S |
$147.31 |
$536,638 |
D/D |
(3,643) |
13,641 |
|
- |
|
| Gorsky Alex |
Chairman, CEO |
• • – |
2018-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,674 |
322,885 |
|
- |
|
| Fasolo Peter |
Exec VP, Chief HR Officer |
• • – |
2018-12-04 |
4 |
S |
$146.68 |
$6,096,552 |
D/D |
(41,563) |
78,327 |
|
- |
|
| Fasolo Peter |
Exec VP, Chief HR Officer |
• • – |
2018-12-04 |
4 |
OE |
$90.44 |
$4,020,237 |
D/D |
41,563 |
119,890 |
|
- |
|
| Fasolo Peter |
Exec VP, Chief HR Officer |
• • – |
2018-12-03 |
4 |
S |
$146.32 |
$18,308,689 |
D/D |
(125,132) |
78,327 |
|
- |
|
| Fasolo Peter |
Exec VP, Chief HR Officer |
• • – |
2018-12-03 |
4 |
OE |
$90.44 |
$11,777,919 |
D/D |
125,132 |
203,459 |
|
- |
|
| Sneed Michael E |
EVP, Global Corp Aff & COO |
• • – |
2018-11-23 |
4 |
S |
$142.46 |
$4,407,985 |
D/D |
(30,943) |
39,874 |
|
- |
|
| Sneed Michael E |
EVP, Global Corp Aff & COO |
• • – |
2018-11-23 |
4 |
OE |
$58.33 |
$1,804,905 |
D/D |
30,943 |
70,817 |
|
- |
|
| Gorsky Alex |
Chairman, CEO |
• • – |
2018-11-16 |
4 |
S |
$145.96 |
$38,600,968 |
D/D |
(264,465) |
336,559 |
|
- |
|
| Gorsky Alex |
Chairman, CEO |
• • – |
2018-11-16 |
4 |
OE |
$62.20 |
$16,500,026 |
D/D |
264,465 |
601,024 |
|
- |
|
| Kapusta Ronald A |
Controller, CAO |
• • – |
2018-11-08 |
4 |
S |
$145.15 |
$1,225,200 |
D/D |
(8,441) |
17,284 |
|
- |
|
| Duato Joaquin |
Vice Chair, Exec Committee |
• • – |
2018-11-07 |
4 |
S |
$144.36 |
$5,774,480 |
D/D |
(40,000) |
93,555 |
|
- |
|
| Duato Joaquin |
Vice Chair, Exec Committee |
• • – |
2018-11-07 |
4 |
OE |
$58.33 |
$2,517,526 |
D/D |
40,000 |
133,555 |
|
- |
|
1526 Records found
|
|
Page 16 of 62 |
|
|
1.61 (1.05%) 
